Patents Assigned to VITTI LABS
  • Patent number: 12123022
    Abstract: Disclosures herein are directed to first compositions comprising exosomes and extracellular matrix components and their use thereof. Also described are methods and kits wherein these first compositions are packaged and used with second compositions comprising mesenchymal stem cells. The first and second compositions are derived from the same tissue source using tangential flow filtration.
    Type: Grant
    Filed: January 31, 2023
    Date of Patent: October 22, 2024
    Assignee: Vitti Labs
    Inventor: Philipp Vitti
  • Publication number: 20230112339
    Abstract: Disclosures herein are directed to first compositions comprising exosomes and extracellular matrix components and their use thereof. Also described are methods and kits wherein these first compositions are packaged and used with second compositions comprising mesenchymal stem cells. The first and second compositions are derived from the same tissue source using tangential flow filtration.
    Type: Application
    Filed: October 18, 2022
    Publication date: April 13, 2023
    Applicant: Vitti Labs
    Inventor: Philipp Vitti
  • Publication number: 20220133803
    Abstract: Disclosed is a system and method for isolating large quantities of viable, undamaged exosomes from liquid, cell-free mesenchymal stem cell cultures using tangential flow filtration.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 5, 2022
    Applicant: VITTI LABS
    Inventor: Philipp R. VITTI